EATG » Toward an effective strategy to combat HIV, hepatitis C and the opioid epidemic: Recommendations for policy makers

Toward an effective strategy to combat HIV, hepatitis C and the opioid epidemic: Recommendations for policy makers

A dramatic increase in opioid use has led to drug-related overdose deaths surpassing motor vehicle accidents as the leading cause of mortality among adults under 50 in the U.S. In the most recent estimates, 63,632 people died from drug-related causes in just one year (2016). Dubbed an opioid epidemic by the U.S. Drug Enforcement Agency (DEA), this public health crisis has spurred a wide array of efforts to increase access to addiction treatment services, reduce trafficking of high-potency synthetic opioid drugs, and reduce overprescribing of prescription drugs.

However, an underappreciated concern is the intersection between opioid use and infectious diseases such as HIV and hepatitis C (HCV), infections that are efficiently transmitted via shared syringes or other injection equipment. A coherent legislative strategy is urgently needed to holistically and effectively address this trifecta of public health threats.

Read the full report here.

Share on FacebookTweet about this on TwitterShare on Google+Pin on PinterestShare on LinkedIn
Source:
amfAR
News categories: Substance use, Advocacy